As generative AI systems raise novel challenges around data privacy, scope, temporality, and autonomy that undermine traditional consent mechanisms, experts call for new frameworks involving collective governance, technical safeguards, and legal reforms to protect data rights in the AI era.
Chip stocks plunged despite being exempted from tariffs, signaling persistent industry headwinds stemming from potential semiconductor-specific tariffs, weakening demand due to existing tariffs, uncertainties around export restrictions, AI regulations, and infrastructure project pullbacks.
Amazon's groundbreaking 'Buy for Me' feature harnesses AI to seamlessly purchase products from external brands' sites, expanding shopping reach while maintaining Amazon's convenience and security.
Augment Code introduces 'Augment Agent', a powerful AI for seamless software engineering that achieves record-breaking scores on industry benchmarks, offers real-time code synchronization, enterprise-grade security, and adapts to individual coding styles.
DeepMind's 145-page paper warns of potential 'severe harm' from advanced AI by 2030, proposing safeguards like access controls and AI interpretability, though some experts dispute the premises.
Scientists developed a starfish-shaped wearable device that leverages AI to precisely track heart health in real time with over 90% accuracy, even during movement, enabling comfortable long-term at-home monitoring with wireless charging and skin-friendly materials.
Agility Robotics secures $400 million funding at $1.75 billion valuation as its 5-foot-9-inch humanoid robot Digit gains enhanced battery life, autonomous charging, and improved grasping capabilities while competing for warehouse automation dominance against rivals in the rapidly expanding humanoid robotics market.
Chinese companies employ various tactics, including smuggling, exploiting loopholes, leveraging subsidiaries, utilizing cloud services, and innovating with alternative chips, to circumvent U.S. restrictions on advanced semiconductor technology.
SoftBank Group plans to invest up to $40 billion in OpenAI, with $10 billion upfront and up to $30 billion more by 2026, to support OpenAI's quest for Artificial General Intelligence and ultimately Artificial Super Intelligence for the advancement of humanity.
Google-backed AI drug discovery startup Isomorphic Labs secured a staggering $600 million in funding led by Thrive Capital, fueling its AI engine's development and advancing partnerships with pharmaceutical giants like Eli Lilly and Novartis worth billions to revolutionize drug design.